It is not known whether a functional substitute for FKRP that could delay the progression of LGMD2I exists, or whether all glycosylated α-dystroglycan originates from what basic functionality the mutated FKRP retains. This evidence concerns the gene FKRP and autosomal recessive limb-girdle muscular dystrophy type 2I.